Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
07 April 1994Website:
http://sanaramedtech.comNext earnings report:
13 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 35 min agoDividend
Analysts recommendations
Institutional Ownership
SMTI Latest News
Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2024 Earnings Conference Call on May 14, 2024 at 9:00 AM ET with company representatives Callon Nichols, Ron Nixon, Mike McNeil, and Seth Yon. Moderator Ian Cassel from IFCM Operator. Welcome to the Sanara MedTech Inc. First Quarter Results and Business Update Conference Call. All participants are currently in a listen-only mode.
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2023 Results Conference Call November 14, 2023 9:00 AM ET Company Participants Callon Nichols - Vice President of Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - Chief Executive Officer Mike McNeil - CFO & Corporate Secretary Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - IFCM Niraj Gupta - GCI Partners Operator Greetings, and welcome to the Sanara MedTech Incorporated Third Quarter 2023 Results and Business Update Call. At this time, all participants are in a listen-only mode.
Sanara Medtech, Inc. (NASDAQ:SMTI ) Q2 2023 Earnings Conference Call August 15, 2023 9:00 AM ET Company Participants Callon Nichols - VP, Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - CEO Mike McNeil - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCap Club Operator Greetings. Welcome to the Sanara MedTech Inc. Second Quarter 2023 Results and Business Update Conference Call.
The heavy selling pressure might have exhausted for Sanara MedTech Inc. (SMTI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
FORT WORTH, TX, May 03, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today details for the release of its results for the quarter ended March 31, 2023.
What type of business is Sanara MedTech?
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
What sector is Sanara MedTech in?
Sanara MedTech is in the Healthcare sector
What industry is Sanara MedTech in?
Sanara MedTech is in the Medical Instruments & Supplies industry
What country is Sanara MedTech from?
Sanara MedTech is headquartered in United States
When did Sanara MedTech go public?
Sanara MedTech initial public offering (IPO) was on 07 April 1994
What is Sanara MedTech website?
https://sanaramedtech.com
Is Sanara MedTech in the S&P 500?
No, Sanara MedTech is not included in the S&P 500 index
Is Sanara MedTech in the NASDAQ 100?
No, Sanara MedTech is not included in the NASDAQ 100 index
Is Sanara MedTech in the Dow Jones?
No, Sanara MedTech is not included in the Dow Jones index
When was Sanara MedTech the previous earnings report?
No data
When does Sanara MedTech earnings report?
The next expected earnings date for Sanara MedTech is 13 November 2024